Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.763 | 0.320 | 14 | 45189123 | stop gained | C/T | snv | 1.2E-03 | 1.0E-03 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 6 | 2005 | 2016 | ||||||
|
14 | 45175424 | synonymous variant | T/C | snv | 7.9E-03 | 3.0E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
14 | 45175424 | synonymous variant | T/C | snv | 7.9E-03 | 3.0E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
1.000 | 0.080 | 14 | 45188848 | frameshift variant | AT/- | del | 4.0E-06 |
|
Neoplasms; Eye Diseases | 0.700 | 0 | ||||||||||
|
0.776 | 0.200 | 14 | 45198718 | stop gained | C/A;T | snv | 4.0E-06; 1.0E-03 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 0 | ||||||||||
|
0.776 | 0.200 | 14 | 45198718 | stop gained | C/A;T | snv | 4.0E-06; 1.0E-03 |
|
0.700 | 0 | |||||||||||
|
0.763 | 0.320 | 14 | 45189123 | stop gained | C/T | snv | 1.2E-03 | 1.0E-03 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 0 | |||||||||
|
0.763 | 0.320 | 14 | 45189123 | stop gained | C/T | snv | 1.2E-03 | 1.0E-03 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases | 0.700 | 0 | |||||||||
|
0.763 | 0.320 | 14 | 45189123 | stop gained | C/T | snv | 1.2E-03 | 1.0E-03 |
|
0.700 | 0 | ||||||||||
|
0.763 | 0.320 | 14 | 45189123 | stop gained | C/T | snv | 1.2E-03 | 1.0E-03 |
|
0.700 | 0 | ||||||||||
|
1.000 | 14 | 45167106 | frameshift variant | CAGAGAAGCCTTC/- | delins |
|
0.700 | 0 | |||||||||||||
|
1.000 | 14 | 45183764 | intron variant | A/G | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 0.120 | 14 | 45175098 | stop gained | G/T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 0 | |||||||||||
|
1.000 | 0.120 | 14 | 45175902 | stop gained | G/T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 0 | |||||||||||
|
1.000 | 0.120 | 14 | 45176757 | frameshift variant | -/G | ins |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 0 | |||||||||||
|
1.000 | 0.120 | 14 | 45183775 | stop gained | C/G | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 0 | |||||||||||
|
1.000 | 14 | 45159189 | frameshift variant | -/A | delins |
|
0.700 | 0 | |||||||||||||
|
0.776 | 0.200 | 14 | 45198718 | stop gained | C/A;T | snv | 4.0E-06; 1.0E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2015 | 2017 | |||||||
|
0.776 | 0.200 | 14 | 45198718 | stop gained | C/A;T | snv | 4.0E-06; 1.0E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2015 | 2017 | |||||||
|
0.763 | 0.320 | 14 | 45189123 | stop gained | C/T | snv | 1.2E-03 | 1.0E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2016 | 2017 | ||||||
|
0.763 | 0.320 | 14 | 45189123 | stop gained | C/T | snv | 1.2E-03 | 1.0E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2016 | 2017 | ||||||
|
0.776 | 0.200 | 14 | 45198718 | stop gained | C/A;T | snv | 4.0E-06; 1.0E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2015 | 2017 | |||||||
|
0.776 | 0.200 | 14 | 45198718 | stop gained | C/A;T | snv | 4.0E-06; 1.0E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.776 | 0.200 | 14 | 45198718 | stop gained | C/A;T | snv | 4.0E-06; 1.0E-03 |
|
Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.776 | 0.200 | 14 | 45198718 | stop gained | C/A;T | snv | 4.0E-06; 1.0E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 |